NCT02423876 2023-09-06
Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery
University of Wisconsin, Madison
Phase 3 Completed
Clinical Trials
11 trialsNCT01812759 2021-06-29
Fentanyl for Breakthrough Pain in the Emergency Department
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02459964 2021-06-16
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00305110 2018-08-20
Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
Montefiore Medical Center
Phase 2 Completed
NCT01824524 2014-08-15
A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer
Xian-Janssen Pharmaceutical Ltd.
Phase 1 Completed
NCT00295945 2014-05-20
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
University of California, San Francisco
Completed
NCT02084355 2014-03-12
Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain
Gyeongsang National University Hospital
Phase 3 Unknown
NCT01205126 2014-02-03
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 3 Completed
NCT01648699 2013-10-11
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
Phase 4 Terminated
NCT00003115 2011-02-23
Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy
Roswell Park Cancer Institute
Phase 3 Completed
NCT00822614 2009-01-14
FINDS
Akela Pharma, Inc.
Phase 3 Unknown